Cargando…

HMGA1 As a Potential Prognostic and Therapeutic Biomarker in Breast Cancer

BACKGROUND: High-mobility group AT-hook1 (HMGA1) protein plays an important role in various diseases. However, the contribution of HMGA1 in breast cancer remains to be tapped. METHODS: The expression of HMGA1 was analyzed in The Cancer Genome Atlas (TCGA) and TIMER database, and immunohistochemistry...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tian, Zhou, Ting, Fu, Fangfang, Han, Yingyan, Li, Yan, Yuan, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720233/ https://www.ncbi.nlm.nih.gov/pubmed/36479041 http://dx.doi.org/10.1155/2022/7466555

Ejemplares similares

Clinical Implications of Extracellular HMGA1 in Breast Cancer
por: Méndez, Olga, et al.
Publicado: (2019)

Cyclin genes as potential novel prognostic biomarkers and therapeutic targets in breast cancer
por: Liu, Nian-Qiu, et al.
Publicado: (2022)

HMGA1-pseudogenes and cancer
por: De Martino, Marco, et al.
Publicado: (2016)

HMGA2: A Biomarker in Gynecologic Neoplasia
por: Wei, Jian-Jun
Publicado: (2022)

HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer
por: Li, Anqi, et al.
Publicado: (2016)

Circular RNA: A potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2021)

Prognostic Significance of HMGA1 Expression in Lung Cancer Based on Bioinformatics Analysis
por: Saed, Lias, et al.
Publicado: (2022)

EIF4G1 Is a Potential Prognostic Biomarker of Breast Cancer
por: Li, Kun, et al.
Publicado: (2022)

Overexpression of HMGA1 Figures as a Potential Prognostic Factor in Endometrioid Endometrial Carcinoma (EEC)
por: Palumbo Júnior, Antonio, et al.
Publicado: (2019)

High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential
por: Wang, Lu, et al.
Publicado: (2022)

TGF-β1 induces HMGA1 expression in human breast cancer cells: Implications of the involvement of HMGA1 in TGF-β signaling
por: ZU, XUYU, et al.
Publicado: (2015)

ATP6AP1 is a potential prognostic biomarker and is associated with iron metabolism in breast cancer
por: Tian, Ye, et al.
Publicado: (2022)

MYC-regulated pseudogene HMGA1P6 promotes ovarian cancer malignancy via augmenting the oncogenic HMGA1/2
por: Tian, Xiaoxue, et al.
Publicado: (2020)

Correction: HDAC5, a potential therapeutic target and prognostic biomarker, promotes proliferation, invasion and migration in human breast cancer
por: Li, Anqi, et al.
Publicado: (2017)

HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer
por: Mansoori, Behzad, et al.
Publicado: (2021)

HMGA1 exacerbates tumor growth through regulating the cell cycle and accelerates migration/invasion via targeting miR-221/222 in cervical cancer
por: Fu, Fangfang, et al.
Publicado: (2018)

CRMP1 Inhibits Proliferation of Medulloblastoma and Is Regulated by HMGA1
por: Li, Kay Ka-Wai, et al.
Publicado: (2015)

HMGA1 in cancer: Cancer classification by location
por: Wang, Yuhong, et al.
Publicado: (2019)

TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion
por: Zhong, Jing, et al.
Publicado: (2017)

HMGA1 regulates the Plasminogen activation system in the secretome of breast cancer cells
por: Resmini, Giulia, et al.
Publicado: (2017)

Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas
por: Pareja, Fresia, et al.
Publicado: (2019)

CRISPR/Cas9(-3NLS)/sgHMGA2@PDA nanosystem is the potential efficient gene editing therapy for gastric cancer with HMGA2 high expression
por: Wu, Zhouying, et al.
Publicado: (2022)

GNPNAT1 promotes the stemness of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2023)

Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma
por: Chang, Kai-Ping, et al.
Publicado: (2015)

NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma
por: Guo, Qiuyun, et al.
Publicado: (2019)

Clinicopathological and prognostic significance of HMGA2 overexpression in gastric cancer: a meta-analysis
por: Zhu, Jingyi, et al.
Publicado: (2017)

GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer
por: Shi, Yan-long, et al.
Publicado: (2022)

Cytochrome P450 2U1 Is a Novel Independent Prognostic Biomarker in Breast Cancer Patients
por: Luo, Bin, et al.
Publicado: (2020)

HMGA2 regulates lung cancer proliferation and metastasis
por: Gao, Xiaotian, et al.
Publicado: (2017)

CISD1 Is a Breast Cancer Prognostic Biomarker Associated with Diabetes Mellitus
por: Liu, Fangfang, et al.
Publicado: (2022)

Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC
por: Strell, Carina, et al.
Publicado: (2017)

CTHRC1 is a Potential Prognostic Biomarker and Correlated with Macrophage Infiltration in Breast Cancer
por: Wang, Zejun, et al.
Publicado: (2022)

Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression
por: Gundlach, Jan-Paul, et al.
Publicado: (2021)

HMGA2 promotes the migration and invasion of gallbladder cancer cells and HMGA2 knockdown inhibits angiogenesis via targeting VEGFA
por: Yan, Jun, et al.
Publicado: (2022)

Cytological Immunostaining of HMGA2, LRP1B, and TP63 as Potential Biomarkers for Triaging Human Papillomavirus-Positive Women()
por: Jiang, Yunhui, et al.
Publicado: (2019)

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma Pathogenesis
por: Wu, Geting, et al.
Publicado: (2021)

Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer
por: Maurizio, Elisa, et al.
Publicado: (2016)

HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28 and let-7 miRNAs in oral squamous cell carcinoma
por: Sterenczak, Katharina Anna, et al.
Publicado: (2014)

Hmga1/Hmga2 double knock-out mice display a “superpygmy” phenotype
por: Federico, Antonella, et al.
Publicado: (2014)

The Fragment HMGA2-sh-3p20 from HMGA2 mRNA 3′UTR Promotes the Growth of Hepatoma Cells by Upregulating HMGA2
por: Wang, Yuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bg3joj58pemuuu7ujd0c2ga5s9